Cargando…

Anthropometric measures at different ages and endometrial cancer risk

BACKGROUND: Endometrial cancer is strongly associated with body mass index (BMI), but the influence of BMI history and of different types of obesity is uncertain. ETHODS: M A case–control study was carried out in Italy including 454 cases and 908 controls admitted to hospital for acute non-hormone-r...

Descripción completa

Detalles Bibliográficos
Autores principales: Maso, L Dal, Tavani, A, Zucchetto, A, Montella, M, Ferraroni, M, Negri, E, Polesel, J, Decarli, A, Talamini, R, La Vecchia, C, Franceschi, S
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068501/
https://www.ncbi.nlm.nih.gov/pubmed/21386846
http://dx.doi.org/10.1038/bjc.2011.63
_version_ 1782201257187868672
author Maso, L Dal
Tavani, A
Zucchetto, A
Montella, M
Ferraroni, M
Negri, E
Polesel, J
Decarli, A
Talamini, R
La Vecchia, C
Franceschi, S
author_facet Maso, L Dal
Tavani, A
Zucchetto, A
Montella, M
Ferraroni, M
Negri, E
Polesel, J
Decarli, A
Talamini, R
La Vecchia, C
Franceschi, S
author_sort Maso, L Dal
collection PubMed
description BACKGROUND: Endometrial cancer is strongly associated with body mass index (BMI), but the influence of BMI history and of different types of obesity is uncertain. ETHODS: M A case–control study was carried out in Italy including 454 cases and 908 controls admitted to hospital for acute non-hormone-related conditions. Odds ratios (ORs) and 95% confidence intervals (CIs) were computed using multivariate logistic and spline regression models. RESULTS: The OR for BMI >30 at diagnosis compared with 20 to <25 kg m(−2) was 4.08 (95% CI: 2.90–5.74). The association for BMI was monotonic with a possible steeper increase for BMI above 28. Conversely, waist-to-hip ratio (WHR) showed a bell shaped curve with increased OR (2.10; 95% CI: 1.43–3.09) in the intermediate tertile only. After stratification by BMI at diagnosis, history of weight loss and BMI at age 30 did not influence endometrial cancer risk. History of obesity in middle age had a weak and not significant adverse effect among obese women (OR=1.60; 95% CI: 0.52–4.96). CONCLUSION: The predominant importance of recent weight compared to lifetime history, justifies encouraging weight reduction in women at any age.
format Text
id pubmed-3068501
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-30685012012-03-29 Anthropometric measures at different ages and endometrial cancer risk Maso, L Dal Tavani, A Zucchetto, A Montella, M Ferraroni, M Negri, E Polesel, J Decarli, A Talamini, R La Vecchia, C Franceschi, S Br J Cancer Epidemiology BACKGROUND: Endometrial cancer is strongly associated with body mass index (BMI), but the influence of BMI history and of different types of obesity is uncertain. ETHODS: M A case–control study was carried out in Italy including 454 cases and 908 controls admitted to hospital for acute non-hormone-related conditions. Odds ratios (ORs) and 95% confidence intervals (CIs) were computed using multivariate logistic and spline regression models. RESULTS: The OR for BMI >30 at diagnosis compared with 20 to <25 kg m(−2) was 4.08 (95% CI: 2.90–5.74). The association for BMI was monotonic with a possible steeper increase for BMI above 28. Conversely, waist-to-hip ratio (WHR) showed a bell shaped curve with increased OR (2.10; 95% CI: 1.43–3.09) in the intermediate tertile only. After stratification by BMI at diagnosis, history of weight loss and BMI at age 30 did not influence endometrial cancer risk. History of obesity in middle age had a weak and not significant adverse effect among obese women (OR=1.60; 95% CI: 0.52–4.96). CONCLUSION: The predominant importance of recent weight compared to lifetime history, justifies encouraging weight reduction in women at any age. Nature Publishing Group 2011-03-29 2011-03-08 /pmc/articles/PMC3068501/ /pubmed/21386846 http://dx.doi.org/10.1038/bjc.2011.63 Text en Copyright © 2011 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Epidemiology
Maso, L Dal
Tavani, A
Zucchetto, A
Montella, M
Ferraroni, M
Negri, E
Polesel, J
Decarli, A
Talamini, R
La Vecchia, C
Franceschi, S
Anthropometric measures at different ages and endometrial cancer risk
title Anthropometric measures at different ages and endometrial cancer risk
title_full Anthropometric measures at different ages and endometrial cancer risk
title_fullStr Anthropometric measures at different ages and endometrial cancer risk
title_full_unstemmed Anthropometric measures at different ages and endometrial cancer risk
title_short Anthropometric measures at different ages and endometrial cancer risk
title_sort anthropometric measures at different ages and endometrial cancer risk
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068501/
https://www.ncbi.nlm.nih.gov/pubmed/21386846
http://dx.doi.org/10.1038/bjc.2011.63
work_keys_str_mv AT masoldal anthropometricmeasuresatdifferentagesandendometrialcancerrisk
AT tavania anthropometricmeasuresatdifferentagesandendometrialcancerrisk
AT zucchettoa anthropometricmeasuresatdifferentagesandendometrialcancerrisk
AT montellam anthropometricmeasuresatdifferentagesandendometrialcancerrisk
AT ferraronim anthropometricmeasuresatdifferentagesandendometrialcancerrisk
AT negrie anthropometricmeasuresatdifferentagesandendometrialcancerrisk
AT poleselj anthropometricmeasuresatdifferentagesandendometrialcancerrisk
AT decarlia anthropometricmeasuresatdifferentagesandendometrialcancerrisk
AT talaminir anthropometricmeasuresatdifferentagesandendometrialcancerrisk
AT lavecchiac anthropometricmeasuresatdifferentagesandendometrialcancerrisk
AT franceschis anthropometricmeasuresatdifferentagesandendometrialcancerrisk